Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-11

FDA Approved: NIKKI — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for NIKKI, a generic drospirenone/ethinyl estradiol combination oral contraceptive. The approval re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NIKKI (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for NIKKI (DROSPIRENONE AND ETHINYL ESTRADIOL)